Akadémiai Congress

1st Congress of Fatty Liver and Metabolic Syndrome

From Basic Science to the Clinical Praxis

Budapest, 12-14. November 2009.

Hotel Ramada Resort – Aquaworld Budapest

1044 Budapest, Íves út 16.

Our international meeting with leader scientists and clinicians from more than 20 countries presents the up-to-date knowledge on the study and treatment of fatty liver disease, metabolic syndrome and relating diseases, and offers the best atmosphere to discuss groundbreaking research and progressive clinical treatments.

Main topics

Molecular biology and pathophysiology of altered liver function

Clinical appearances (fatty liver, NASH, HCC)

Fatty liver disease in children

Dyslipidemia and fatty liver

Diabetes and fatty liver

Fatty liver and viral hepatitis

Recent insights and new directions in therapy

Preliminary Program 

12 November, Thursday

8.00-19.00 Registration

10.00-19.00 Poster viewing

 

SESSION 1 (Part 1): Molecular biology of lipid accumulation in the liver

Chairmen: Mandl, J. (Hungary), Chatgilialoglu, C. (Italy) 

09.30-09.50 József Mandl (Hungary): The role of endoplasmic reticulum in the metabolic syndrome

09.50-10.10 Chrys Chatgilialoglu (Italy): Trans fatty acids in membranes: from nutrition to radical stress

10.10-10.30 Grzegorz Bartosz (Poland): Reactive oxygen species: Destroyers or messengers in non-alcoholic fatty liver?

10.30-10.45 Tao Zeng, Ke-Qin Xie (P.R. China): Garlic oil prevented acute ethanol-induced hepatosteatosis via inhibition of microsomal oxidases and activation of antioxidant system

10.45-11.30 Coffee break

 

SESSION 1 (Part 2): Molecular biology of lipid accumulation in the liver

Chairmen: Eckl, P. (Austria), Bánhegyi, G. (Italy)

11.30-11.50 Peter Eckl, A. Alija, W. Siems, E. Bojaxhi, C. Vogl, G. Martano, H. Stutz, N. Bresgen (Austria): Toxicological properties of β-carotene in the liver

11.50-12.10 Miklós Csala (Hungary): Prereceptorial glucocorticoid activation: a means of nutrient sensing with implications in metabolic syndrome

12.10-12.30 Gábor Bánhegyi (Italy): Nonalcoholic fatty liver disease and endoplasmic reticulum redox state

12.30-12.45 Zemin Yao (Canada) The expression of new protein factors on hepatic lipoprotein production and on the diabetic dyslipidemia and diabetic hepatosteatosis

12.45-13.00 Kasey C. Vickers, A.M. Aponte, A.T. Remaley (USA): A Systems Biology Approach to the Hepatic Response to Dietary Fat Reveals a Novel Mechanism of Cholesterol Regulation

13.00-14.00 Lunch

 

SESSION 2: Molecular biology of lipid accumulation in the liver

Chairmen: Guéraud, F. (France), Vesely, J. (Czech Republic)

14.00-14.20 Françoise Guéraud (France): Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways

14.20-14.40 Péter Fülöp (Hungary): Molecular biology of lipid accumulation in the liver

14.40-15.00 Jaroslav Vesely (Czech Republic) Peroxisome Proliferator-Activated Receptors in Liver Pathophysiology

15.00-15.20 Martha C. Garcia, T. J. Flynn (USA): Evaluation of gender differences in response to hepatotoxicants using an in vitro fatty liver cell model

15.20-15.30 Paola Brun, D.Cavallo, S. Bressan, S. Signori, S. Lancillotti, D. Martines, I. Castagliuolo (Italy): Lipopolysaccharide-induced oxidative stress contributes to Hepatic Stellate Cells activation in fatty liver

15.30-16.00 Coffee break

 

SESSION 3: Free papers

Chairmen: Szollár, L. (Hungary), Bartosz, G. (Poland)

16.00-16.20 Mamun-Al-Mahtab (Bangladesh): Characteristics of patients with NAFLD in Bangladesh

16.20-16.40 RB Singh: Metabolic Syndrome: A disease of the brain

16.40-16.50 Aoun Manar, M. Jullien, G. Fouret, F. Casas, C. Wrutniak-Cabello, MA. Carbonneau, JP. Cristol, C. Coudray, C. Feillet-Coudray (France): A grape polyphenol extract reduces liver lipid content in rats fed a high fat-high sucrose diet: the SIRT1/AMPK signalling pathway

16.50-17.00 Wolfgang Kratzer, Mark M. Haenle; Atilla S. Akinli; Bernhard O. Boehm (Germany): Prevalence and risk factors of focal sparing in hepatic steatosis

17.00-17.10 Fabio Santos Lira, A. Shimura Yamashita, D. Caetano Gonçalves, Waldecir, P. Lima, L. C. Carnevali, J. Cesar Rosa, E. Chagas Caperuto, L. F. Costa Rosa*, M. Seelaender (Brazil, *in Memorian): Exercise increases liver fatty acid oxidation and prevents steatosis in tumour-bearing rats

17.10-17.20 Mary G. Murphy (P. D. Acott, J. Upham, JFS. Crocker, L. Geldenhuys, P. O'Regan (Canada): Molecular mechanism of petrochemical-induced nonalcoholic fatty liver

17.20-17.30 Markus M. Schmid, B. J. Connemann, R. C. Wolf, C. Eisenbach, C. Flechtenmacher, C. Schönfeldt-Lecuona (Germany): Fatty degeneration and acute liver failure with valproic acid and duloxetine

17.30-17.40 Gaetano Serviddio, F. Bellanti, A.D. Romano, R. Tamborra, T. Rollo, M. Blonda, D. Bruno, G. Vendemiale, E. Altomare (Italy): Oxidative stress, mitochondrial dysfunction are associated with the opening of permeability transition pore in a rodent model of NAFLD

17.40-17.50 Renata Silverio (Brazil): L-carnitine counteracts cancer cachexia- associated steatosis in rats

17.50-18.00 S. Zucoloto, G.R. Oliveira, A.K. Sankarankutty, O. Castro e Silva, J. Ferreira, C. Kurachi, H. Vannuchi, A.A. Jordão Jr., J.S. Marchini and V.S. Bagnato (Brazil): Fluorescence spectroscopy to diagnoses hepatic steatosis in a rat model of fatty liver

19.30-20.30 Concert

20.30 Dinner

13 November, Friday

08.00-19.00 Registration

09.00-19.00 Poster viewing

 

CONSENSUS MEETING (Part 1): Consensus/Index for Fatty Liver

Moderator: Fehér, J. (Hungary)

The purpose of his presentation is to create a platform to come up with an International Consensus on how to indicate Non-Alcoholic Fatty Liver Disease.

08.45-09.05 K. T. Shenoy (India): The need for an international NAFLD-Index

09.05-09.20 Mamun-Al-Mahtab (Bangladesh): APRI is not useful in predicting hepatic fibrosis in non-alcoholic fatty liver disease: experience from a tertiary center in Bangladesh

09.20-09.30 H. Hesham A-Kader, M. D. Merrell, A. J. Lickteig, C. D. Fisher, L. M. Augustine, S. B. Campion, J. E. Manautou,, R. P. Erickson, N. J. Cherrington (USA): Acetaminophen disposition: A novel metabolomic biomarker for non-alcoholic fatty liver disease

09.30-09.45 Gábor Firneisz, T. Varga, A. Somogyi, D. Ghyczy, L. Selmeci, J. Fehér, Zs. Tulassay, G. Lengyel (Hungary): Higher serum dipeptidyl peptidase-4 activity and insulin resistance index in non-alcoholic fatty liver disease in patients with similar degree of obesity

09.45-09.55 Emil Fraenkel, Gy. Szabó, P. Jarčuška, G. Lengyel, J. Fehér (Hungary): Does the carbohydrate deficient transferrin have a diagnostic value in non alcoholic fatty liver?

09.55-10.05 Theresa C. Peterson, S. Caldwell, K.M. Peltekian, M.R. Peterson (Canada): Utility of FSI in documenting fibrosis in NASH

10.05-10.15 Abdulwahhab Al-Isa (Kuwait): Using Two Criteria to Assess the Prevalence of Metabolic Syndrome (MS) among Male Kuwaiti Adolescents

10.15-10.30 Agnes Szebeni (Hungary): Ultrasound in the diagnostic of fatty liver in obesity

10.30-11.00 Coffee break

CONSENSUS MEETING (Part 2): Multifactorial treatment of fatty liver diseases. Metadoxine in fatty liver diseases - Round Table Conference

Moderator: Fehér, J. (Hungary)

11.00-11.15 Janos Fehér (Hungary): Introductory remarks: Therapy modalities in non-alcoholic steatohepatitis

11.15-12.30 Participants from Brazil, Hungary (T. Abel), India (K. T. Chenoy), Italy (Baldacci L), Mexico and South Korea

12.30-14.00 Lunch

SESSION 4: Pathology - pathophysiology

Chairmen: Zarkovic, N. (Croatia), Poli, G. (Italy)

14.00-14.20 Lajos Szollár (Hungary): Metabolic Syndrome - a Ghost with Real Weapons?

14.20-14.40 Neven Zarkovic (Croatia): The relevance of lipid peroxidation in liver pathopysiology

14.40-15.00 Giuseppe Poli (Italy): Lipid oxidation, inflammation and fibrosis

15.00-15.15 Gyorgy Trencsenyi (Hungary): Comparison of tumorogenicity of liver and kidney tumors induced by N-nitrosodimethylamine in rats

15.15-15.30 Kamal D. Mehta: Protein kinase C beta (PKCbeta) plays an important role in regulating whole-body's triglyceride homeostasis

15.30-16.00 Coffee break

SESSION 5: Clinical forms (fatty liver, NASH, HCC)

Chairmen: Biasi, F. (Italy), Halmy, L. (Hungary)

16.00-16.20 Fiorella Biasi (Italy): Lipid oxidation and fibrogenesis in cancer progression

16.20-16.35 László Halmy (Hungary): Obesity and fatty liver

16.35-16.50 György Paragh, P. Fülöp (Hungary): The effect of statins on the hepatocyte function

16.50-17.05 Tatjana Ábel (Hungary): Statins in the therapy of fatty liver

17.05-17.25 Giuseppe Carruba (Italy): Estrogen receptor variants may be implicated in carcinogenesis and progression of human hepatocellular carcioma

17.30-18.30 Closed COST B35 Meeting

Chairman: Neven Zarkovic

17.30-18.00 Poster Section

List of accepted poster presentations can be found below.

18.30-19.30 Concert

19.30 Dinner

 

14 November, Saturday

08.30-13.00 Registration

 

SESSION 6: Fatty liver and viral (HBV, HCV) infection

Chairmen: Baumert, T. (Austria), Siddiqui, A. (USA)

09.00-09.20 Thomas Baumert (France): Hepatitis C virus infection and lipid metabolism

09.20-09.40 Aleem Siddiqui (USA): Hepatitis C virus-induced steatosis

09.40-09.55 Gabriella Lengyel (Hungary): Fatty liver and respond to combined peginterferon and ribavirin treatment

09.55-10.10 Béla Lombay, F. Szalay (Hungary): The negative role of insulin resistance for sustained virological response in chronic hepatitis C patients

10.10-10.25 János Osztovits, T. Horváth, E. Horváth, L. Csihi, J. Tax, G. Bekő, T. Tóth, M. Abonyi, M. Kollai, P. Kempler, J. Fehér, H. E. Blum, F. Szalay (Hungary): Autonomic and sensory nerve functions during 48 weeks of anti-HCV treatment. A follow-up study

10.30-11.30 Coffee break

SESSION 7: Free papers

Chairmen: Mamun-Al-Mahtab (Bangladesh), Carruba, G. (Italy)

11.30-11.40 Brun Paola, D. Cavallo, S. Dagnolo, S. Signori, D. Martines, I. Castagliuolo (Italy): Mice carrying a Toll-like receptor 2 mutation on high fat diet show increased accumulation of body fat albeit attenuation of insulin resistance

11.40-11.50 Matthias Heuer, A. Paul, G. M. Kaiser, Z. Mathé, S. Vernadakis, J. P. Neuhaus, F. H. Saner, A. Canbay, J. W. Treckmann (Germany): Nonalcoholic steatohepatitis and liver transplantation experience of the University Hospital of Essen

11.50-12.00 Aoun Manar, G. Fouret, F. Michel, JP. Cristol, C. Coudray, MA. Carbonneau, C. Feillet-Coudray (France): Polyphenols partially prevent hepatic steatosis and modulate liver fatty acid composition in rats fed a high fat-high sucrose diet

12.00-12.10 Gar-Yang Chau, Shyh-Haw Tsay (Taiwan): Evaluation of age-related, different clinicopathological features of patients with resectable hepatocellular carcinoma

12.10-12.20 Marilia Seelaender, DC. Goncalves, FS. Lira, AS. Yamashita, LC. Carnevali Jr., R. EDER, WP. LIMA (Brazil): Conjugated linoleic acid (CLA) fails to reduce steatosis in cachetic tumour-bearing rats

12.20-12.30 R. Saggini, R. G. Bellomo, M. Calvani, R. Calvani (Italy): Personalized rehabilitation approach to Fatty Liver Disease in patients with metabolic syndrome

12.30-12.40 Yelisyeyeva O., Cherkas A., Semen Kh., Serhiyenko V., Serhiyenko О. ( Danylo Halytsky National Medical University, Lviv, Ukraine): The efficiency of Amaranth oil for correction of oxidative stress and improvement of heart rate variability in patients with type 2 Diabetes mellitus

12.40-12.50 Güngör Kanbak (Turkey): Alchol toxicity and fatty liver preventive effects of betaine and s-adenosyl methionine

12.50-13.00 Closing remarks

13.00-14.00 Lunch

 

Poster presentations

1. Baginskaya N.V.¹, Ilnitskaya C.I.¹, Perepechaeva M.L. ², Pivovarova E.N.¹, Kaledin V.I.¹ (¹Institute of Cytology and Genetics SB RAS, Russia, ² Institute of molecular biology and biophysics SB RAMS, Russia): Induction of fatty liver by fasting in mouse strain disposed to metabolic syndrome development.

2. Barchetta Ilaria, Cavallo M.G., Angelico F., Del Ben M., Fraioli A., Morini S., Pozzilli P.: Association between vitamin D, cardiovascular risk factors and non-alcoholic fatty liver disease (NAFLD) in Italian patients with the metabolic syndrome.

3. Kasapoglu Benan: Does the Chronic Intermittant Hypoxia Link Between Obstructive Sleep Apnea and Fatty Liver Diseas?
   

4. Kelly Décordé¹, Anta Agne¹, Dominique Lacan², Jeanne Ramos³, Gilles Fouret⁴, Emilie Ventura¹, Christine Feillet-Coudray⁴, Jean-Paul Cristol¹, Jean-max Rouanet¹ (¹UMR 204 Prevention of Malnutritions and Linked Pathologies, University of Montpellier, France., ²Bionov Sarl, Agroparc Site, Avignon, France., ³Pathologic Anatomy Laboratory, Hospital Universitary Center Gui de Chauliac, Montpellier, France., ⁴UMR 866 Cellular Differenciation & Growth, INRA, Montpellier, France): Preventive effect of a melon extract rich in superoxide scavenging activity on obesity, oxidative stress and non alcoholic steatohepatitis in hamsters fed a high fat diet.
   

5. Forni G.L.¹, Villa R.¹, Carrara P.¹, Trabacca M.S.², Balocco M.¹ (¹Centro della Microcitemia e delle Anemie Congenite, E.O. Ospedali Galliera di Genova,Genova, Italy., ²S.C. Medicina Interna, E.O. Ospedali Galliera di Genova, Genova, Italy.): Liver iron overload in patients with unexplained hyperferritinemia, Impaired Fasting Glucose and liver steatosis.

6. Fajfrová J.¹, Šafka V.^2,3, Pavlík V.¹, Hlúbik P.¹ (¹Dept. of Military hygiene, Faculty of military health science University of defence, ²Dept. of physiology Charles University – Faculty of Medicine in Hradec Králové, ³2nd Dept. of Medicine University hospital, Hradec Králové): The relationship between metabolic syndrome components and increased alanine aminotransferase activity.

7. Tatjana Ábel, Alexandra Wimmer, Gabriella Lengyel, Mohamed Gamal Eldin, Attila Kovács, Janos Feher (Outpatient Clinic, National Health Centre, 2nd Department of Internal Medicine, Medical Faculty, Semmelweis University, Budaörs Health Centre, Med Medical Service-providing Ltd. Hungary) The moderate white wine consumption and the insulin resistance.

8. T. Garnol, O. Kučera, P. Křiváková, H. Lotková, T. Roušar, Z. Červinková (Dept. of Physiology, Charles University in Prague, Faculty of Medicine in Hradec Králové, Hradec Králové.): Liver Regeneration After Partial Hepatectomy in the Liver Affected by Non-Alcoholic Fatty Liver Disease.

9. Viktor Hegedűs, Zoltán Mihály, Éva Sárdi, Klára Szentmihályi, Anna Blázovics (2nd Department of Internal Medcine, Semmelweis Univeristy): Molecular biological changes in alimentary induced fatty liver.
   

10. Babaei, Hossein; Sadeghzadeh M; Khoshnevisasl P; Kavandi S. (Paediatrics Ward, Mousavi Hospital, Zanjan University of Medical Sciences): A Femal Child Involved Type 1 Crigler-Najjar Syndrome

11. Hoyoku Nishino（Ritsumeikan University): Prevention of viral-induced liver cancer by myo-inositol, one of the anti-fatty liver food factors

12. Jeong Gyu Lee, HongGi Min, Sangyeoup Lee, YunJin Kim: The association of obesity with elevated alanine aminotransferase
    

13. Lian-Shu Piao, Wonhee Hur, Jeung-Eun Choi, Sung Woo Hong, Kwang Soo Lyoo and Seung Kew Yoon (Department of Internal Medicine & WHO Collaborating Center of Viral Hepatitis, The Catholic University of Korea, Seoul, Korea): Establishment of in vitro model system of hepatic steatosis using hepatocyte

14. Özlem Kar¹, Remise Gelisgen², Füsun Erdenen¹, Esma Altunoğolu¹, Taşkın Rakıcı³, Yüksel Barut³, Abdullah Yüksel¹, Hafize Uzun², Hale Aral⁴, Güvenç Güvenen⁴ (Ministry of Health Istanbul Education and Research Hospital, ¹Internal Medicine Clinics, ³Radiology Department, ⁴Central Clinical Chemistry Laboratory, Istanbul. ²Istanbul University Cerrahpasa Medical School, Biochemistry Department, Istanbul.): Comparison of serum anticardiolipin antibodies and carotid intima media thickness in diabetic patients

15. D. Karawczykowsky¹, W.K.Karcz² (¹ France, ² Germany): Liver histopathology by 100 patients with diabetes type II underwent LSG surgery

16. D Krawczykowski, P Melin, L Nduwayo, W Karcz (Polyclinique Priollet/Courlancy Chalons en Champagne France, Centre hospitalier de Saint Dizier France, Clinics of Surgery Division of bariatric and metabolic surgery Freiburg Germany): Liver biopsy in morbidly obese patients

17. Kjaer, Marte, A., Vegusdal, Anne; Berge, Gerd M.; Galloway, Trina F.; Hillestad, Marie; Krogdahl, Åshild; Holm, Halvor; Ruyter, Bente: Characterisation of lipid transport in Atlantic cod liver when fasted and fed high or low fat diets

18. E. A. Kosenko^1,2, Y. G. Kaminsky^1,2 , C. Montoliu³: AMP deaminase and adenosine deaminase are activated in ammonia intoxication and hepatitis

19. Kucera Otto, Krivakova Pavla, Lotkova Halka, Rousar Tomas, Garnol Tomas, Cervinkova Zuzana. (Department of Physiology, Charles University in Prague, Faculty of Medicine in Hradec Kralove): Is the Rat Liver Affected by Non-Alcoholic Steatosis More Susceptible to Toxic Effect of Thioacetamide?

20. Hagymási K., Mihácsi G., Mezei M., Fehér J., Lengyel G. (Semmelweis University, IInd. Dept. of Internal Medicine): Determination of severity of hepatic steatosis in chronic hepatitis C by computer-assisted morphometric image analysis-correlation with clinical data and treatment response

21. A. Martín-Castillo¹, M. Castells², B. García-Pérez³, M. Sánchez-Polo³, G. Adanez³, I. Ayala⁴ , A. Montes⁴. (¹Department of Medicine, División of Gastroenterology, Santa María del Rosell University Hospital, Cartagena. Murcia, ²Department of Cell Biology, University of Murcia, ³Internal Medicine Service, Virgen de la Arrixaca University Hospital. Murcia, ⁴Department of Animal Medicine and Surgery, Veterinary Faculty, University of Murcia. Murcia. Spain.): Effects of Atorvastain on Progression-Regression of Steatohepatitis in Hyperlipidemic Chickens

22. Ming-Ling Chang, Chau-Ting Yeh, Cheng-Tang Chiu, Deng-Yn Lin: Steatohepatitis mediated by hepatitis C virus core protein is ameliorated by blocking complement activation

23. Mohammed Ibrahim: Curative effect of extracts of Sapindus mukorossi and Rheum emodi in CCl4 induced liver cirrhosis in male rats

24. L. Molnár, A. Noetel, J. Rey, B. Sandelin, M. Scheffler, H.U. Kasper, G. Gerken, A. Canbay, H.P: Dienes and M. Odenthal (Institut für Pathologie, Unversität Köln, Germany): Genetic polymorphisms of the Peroxisome proliferator-activated receptor γ (PPAR γ) and Leptin receptor gene in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

25. Jagoda Rosa, Aleksandra Sinđić¹, Domagoj Jakovac and Josip Rosa¹ (Department of Physiology School of Dentistry, ¹Department of Physiology School of Medicine, University of Zagreb, Zagreb, Croatia): Metabolic Changes in Hepatocytes from Rats on Raw Soybean Diet

26. Karolina Dwi Setyowati¹, Armugam Arunmozhiarasi¹, Tavintharan S.², Wong Michael³, Tan Eng Chun³, Lim Su Chi², Sum Chee Fang² and Jeyaseelan Kandiah¹ (¹Department of Biochemistry, Yong Loo Lin School of Medicine, National, University of Singapore, ²Department of Medicine, Alexandra Hospital, Singapore, ³Health For Life Centre, Alexandra Hospital): MicroRNAs: Potential therapeutic targets for Metabolic Syndrome, a predictor of fatty liver.

27. Satoshi Sugiyama*¹, Toshiya Nakaguchi, Satoshi Yamamoto, Takao Namiki,
    Norimichi Tsumura, Yoichi Miyake (¹Graduate School of Advanced Integration Science, Chiba University): Quantitative Diagnostic System for Abdominal Palpation

28. Sergei Vlasov², V.I. Zoloedov¹, L.A. Miroshnichenko², A.P. Volyinkina¹, I.P. Gorshkov (¹Voronezh State Medical Academy named after Burdenko N. N., ²LLC "Russian Olive", Voronezh, Russia) Amaranth oil impact on improvement of metabolic parameters in adult patient with diabetes type 2.

29. Hafize Uzun¹, Erman Aytac², Gulgun Tahan³, Veysel Tahan^4,5, Remise Gelisgen¹, Omur Tabak⁶, Erol Avsar⁴ (¹Department of Biochemistry, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey., ²Department of General Surgery, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey., ³General Surgery Unit, Institute of Gastroenterology, Marmara University, Istanbul, Turkey. ,⁴Institute of Gastroenterology, Marmara University, Istanbul, Turkey., ⁵Department of Human Researches, University of Pittsburgh, Pittsburgh, PA, USA. ,⁶Department of Internal Medicine, Istanbul Education and Research Hospital, Istanbul, Turkey): Melatonin Prevents Oxidative DNA Damage in Non-Alcoholic Steatohepatitis: An Experimental Study

30. Ladislav Vaško¹, Janka Kubálková¹, Rudolf Kašteľ² (¹Department of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Slovak Republik): Primary human omega-6 and omega-3 ratio intake improvement by animal dietary adjustment

31. Wu Meisheng, Chu Haihong, Cai Xia and Tu Yifeng* (Institute of Analytical Chemistry, Department of Chemistry, Suzhou University, P.R.China): A Nano-functionalized Real-time Electrochemiluminescent Biosensor for Alanine Transaminase Assay

32. Zhaoxiang Han: Effects of PFOs on Carassius Aurats and kinetics models

33. Tadashi Yamaguchi: Quantitative evaluation method of diffuse liver diseases based on characteristics analysis of echo signal

34. Doaa A. Ghareeb¹, Ashraf A. khalil², Hany Hafez³, Mona A. Salem⁴, Nihal F. Mansour (¹Department of Biochemistry, Faculty of science, Alexandria University, ²Department of Protein Technology, Institute of Genetic Engineering and Biotechnology, Mubarak City for Scientific Research, New Borg Elarab, Alexandria, Egypt., ³Department of Zoologyt, Faculty of Science, Cairo University, ⁴Department of Pathology, Faculty of Medicine, Alexandria University, ⁵Faculty of Pharmacy, Alexandria University): From steatosis to steatohepatitis: is there any early diagnostic marker?

35. Ovcharenko N.A., Reshetnikova O.S., Zinchenko O.V., Pinskyy L.L. (Lugansk State Medical University): Morphological features of adjournment lipide granules at patients with chronic hepatitis C and opioid drug addiction